BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12823366)

  • 1. Positron emission tomography for urological tumours.
    Hain SF; Maisey MN
    BJU Int; 2003 Jul; 92(2):159-64. PubMed ID: 12823366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography for prostate, bladder, and renal cancer.
    Schöder H; Larson SM
    Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and monitoring of urological tumors using positron emission tomography.
    Hofer C; Kübler H; Hartung R; Breul J; Avril N
    Eur Urol; 2001 Nov; 40(5):481-7. PubMed ID: 11752853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography in uro-oncology.
    Hain SF
    Cancer Imaging; 2005 Jan; 5(1):1-7. PubMed ID: 16154810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography in urologic oncology.
    Shvarts O; Han KR; Seltzer M; Pantuck AJ; Belldegrun AS
    Cancer Control; 2002; 9(4):335-42. PubMed ID: 12228759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron-emission tomography imaging in urological oncology: Current aspects and developments.
    Rauscher I; Eiber M; Weber WA; Gschwend JE; Horn T; Maurer T
    Int J Urol; 2018 Nov; 25(11):912-921. PubMed ID: 30103285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography in urological oncology.
    Hoh CK; Seltzer MA; Franklin J; deKernion JB; Phelps ME; Belldegrun A
    J Urol; 1998 Feb; 159(2):347-56. PubMed ID: 9649238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].
    Bachor R; Kocher F; Gropengiesser F; Reske SN; Hautmann RE
    Urologe A; 1995 Mar; 34(2):138-42. PubMed ID: 7754585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Various aspects of the lymphographic diagnosis of metastases of urological tumors].
    Elke M
    Radiol Austriaca; 1968; 17(4):275-80. PubMed ID: 5695838
    [No Abstract]   [Full Text] [Related]  

  • 11. PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
    Bouchelouche K; Choyke PL
    PET Clin; 2015 Jul; 10(3):361-74. PubMed ID: 26099672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in urologic oncology: positron emission tomography molecular imaging.
    Bouchelouche K; Oehr P
    Curr Opin Oncol; 2008 May; 20(3):321-6. PubMed ID: 18391633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S80-7. PubMed ID: 12739339
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible role of FDG-PET in the evaluation of urologic malignancies.
    Bender H; Schomburg A; Albers P; Ruhlmann J; Biersack HJ
    Anticancer Res; 1997; 17(3B):1655-60. PubMed ID: 9179213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography in urological malignancy.
    Brush JP
    Curr Opin Urol; 2001 Mar; 11(2):175-9. PubMed ID: 11224748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular positron emission tomography and PET/CT imaging in urological malignancies.
    Powles T; Murray I; Brock C; Oliver T; Avril N
    Eur Urol; 2007 Jun; 51(6):1511-20; discussion 1520-1. PubMed ID: 17275167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [X-ray diagnosis of recurrences in malignant urogenital tumors].
    Koehler PR
    Fortschr Geb Rontgenstr Nuklearmed; 1973; 0(0):suppl:151-2. PubMed ID: 4366593
    [No Abstract]   [Full Text] [Related]  

  • 18. PET in the management of urologic malignancies.
    Kumar R; Zhuang H; Alavi A
    Radiol Clin North Am; 2004 Nov; 42(6):1141-53, ix. PubMed ID: 15488563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of positron emission tomography in urological oncology.
    Rioja J; Rodríguez-Fraile M; Lima-Favaretto R; Rincón-Mayans A; Peñuelas-Sánchez I; Zudaire-Bergera JJ; Parra RO
    BJU Int; 2010 Dec; 106(11):1578-93. PubMed ID: 21078036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear medicine studies of the prostate, testes, and bladder.
    Jana S; Blaufox MD
    Semin Nucl Med; 2006 Jan; 36(1):51-72. PubMed ID: 16356796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.